MarketInOut Stock Screener Log In | Sign Up
 

Viatris Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/17/2026 16:00
Viatris Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization19,192 mln
Float1,155 mln
Earnings Date08/10/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.78
Likely reliable

1-Year Forecast

17.81
Modest upside

Relative Strength

71 / 100
Outperforming

Debt / Equity

0.98
Moderate leverage

Pre-Tax Margin

2%
Break-even

Business Description

Viatris is a global healthcare company founded in 1961 and based in Canonsburg, Pennsylvania, that sells a broad range of medicines across more than a dozen major markets worldwide, including North America, Europe, Asia, and the Middle East. Its product lineup spans branded drugs, generics, and biosimilars, addressing conditions such as heart disease, diabetes, cancer, and respiratory illness, and these are made available through pharmacies, wholesalers, insurers, and governments. The company also partners with other healthcare firms to develop new treatments and supports patients through educational resources and digital health tools.

Key Fundamentals

EPS-0.30
ROE-1.96
RPS12.49
ROIC0.27
ROA-0.79
Interest Cover0.51
EBITDA, mln1,794
EV / EBITDA17.40
EV / EBIT-92.01
Revenue, mln14,563
EV / Revenue2.14

Financial Strength

Altman Z-Score1
Piotroski F-Score 6 / 9
Beneish M-Score-2.78
Price to Intrinsic Value0.65
1-Year Target Price17.81
Short Ratio3.12
Short % of Float3.54

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.25% 31 / 100   
1 Month -3.97% 24 / 100   
2 Months 13.41% 77 / 100   
6 Months 37.02% 89 / 100   
1 Year 81.85% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us